SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical ... Healthcare Global (press release) SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits of TREAKISYM(R) (Bendamustine) in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL). Contact Hiroki Maekawa ... |
